(1R,2S)-2-Cyclohexyl-1-[4-(cyclopropylsulfonyl)phenyl]-N-(5-{[2-(1-pyrrolidinyl)ethyl]sulfanyl}-1,3-thiazol-2-yl)cyclopropanecarboxamide(CAS: 1234703-40-2)

This compound is subject to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations under the European Union, and the Toxic Substances Control Act (TSCA) in the USA. It may also require registration under the EPA and FDA for specific applications. Compliance with local regulations and safety data sheets (SDS) is essential for handling and storage.

There are alternative reagents and methodologies available for synthesis, such as using 2-cyclohexyl-1-[4-(cyclopropylsulfonyl)phenyl]-N-(5-{[2-(1-pyrrolidinyl)ethyl]sulfanyl}-1,3-thiazol-2-yl)cyclopropanecarboxamide analogs or isomers. Common substitutes include variations with different functional groups or simpler structures that can achieve similar outcomes.

The market for this compound is currently stabilizing with a focus on its use in pharmaceutical research, particularly in drug development. Recent research trends indicate a growing interest in its potential applications in anti-inflammatory and anti-cancer treatments. Additionally, there is an increasing trend towards exploring its use in personalized medicine and targeted therapies.

Waste containing this compound should be collected in appropriate containers and transported to a professional waste disposal facility for incineration or chemical treatment. Proper environmental protection measures, including the use of personal protective equipment (PPE) and adherence to local waste management regulations, are crucial. It is recommended to consult with a hazardous waste management expert to ensure compliance with all safety and environmental standards.